The Alkylating Chemotherapeutic Temozolomide Induces Metabolic Stress in <i>IDH1</i>-Mutant Cancers and Potentiates NAD+ Depletion–Mediated Cytotoxicity
Crossref DOI link: https://doi.org/10.1158/0008-5472.CAN-16-2263
Published Online: 2017-08-01
Published Print: 2017-08-01
Update policy: https://doi.org/10.1158/crossmark_policy
Tateishi, Kensuke
Higuchi, Fumi
Miller, Julie J.
Koerner, Mara V.A.
Lelic, Nina
Shankar, Ganesh M.
Tanaka, Shota
Fisher, David E.
Batchelor, Tracy T.
Iafrate, A. John
Wakimoto, Hiroaki
Chi, Andrew S.
Cahill, Daniel P.